Reader’s Links for December 3, 2021

Each day at just after midnight Eastern, a post like this one is created for contributors and readers of this site to upload news links and video links on the issues that concern this site. Most notably, Islam and its effects on Classical Civilization, and various forms of leftism from Soviet era communism, to postmodernism and all the flavours of galloping statism and totalitarianism such as Nazism and Fascism which are increasingly snuffing out the classical liberalism which created our near, miraculous civilization the West has been building since the time of Socrates.

This document was written around the time this site was created, for those who wish to understand what this site is about. And while our understanding of the world and events has grown since then, the basic ideas remain sound and true to the purpose.

So please post all links, thoughts and ideas that you feel will benefit the readers of this site to the comments under this post each day. And thank you all for your contributions.

This is the new Samizdat. We must use it while we can.

About Eeyore

Canadian artist and counter-jihad and freedom of speech activist as well as devout Schrödinger's catholic

59 Replies to “Reader’s Links for December 3, 2021”

  1. Ursula von der Leyen + Albert Bourla Pfizer CEO

    APRIL 28 2021 – NYT – How Europe Sealed a Pfizer Vaccine Deal With Texts and Calls

    The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination campaign. Here’s how it came about.

    BRUSSELS — It was February and things were going from bad to worse for the European Union’s vaccination campaign, and for its top executive, Ursula von der Leyen.

    Much of Europe was in lockdown, people were dying and the bloc was running low on doses of vaccines after its biggest supplier, AstraZeneca, announced production problems. Critics inside and outside the European Union questioned Ms. von der Leyen’s leadership and accused her of mishandling the crisis.

    It was at that low point that she caught a break.

    For a month, Ms. von der Leyen had been exchanging texts and calls with Albert Bourla, the chief executive of Pfizer, another vaccine supplier to the bloc. And as they spoke, two things became clear: Pfizer might have more doses it could offer the bloc — many more. And the European Union would be thrilled to have them.

    That personal diplomacy played a big role in a deal, to be finalized this week, in which the European Union will lock in 1.8 billion doses from Pfizer, which, with its smaller German partner, BioNTech, made the first Covid-19 vaccine to get regulatory approval in the European Union.

    The new contract will include a 900-million-dose order through 2023, with an option for another 900 million, Ms. von der Leyen said in an interview.

    “I am convinced that we are in this for the long haul,” she said.

    The deal will establish the European Union as Pfizer’s biggest single client by far; the company has so far sold 300 million doses to the United States. The contract will permit the European Union to resell or donate the vaccines to partners, empowering it to conduct vaccine diplomacy and support struggling efforts to immunize people in poorer countries.

    Ms. von der Leyen and Mr. Bourla first connected in January, when the pharmaceutical boss had to explain why his company had to cut vaccine supplies temporarily while it upgraded manufacturing facilities in Belgium. In November, the European Union signed an initial deal with the company for 200 million doses, with the option to add 100 million.

    As the improvements at the Belgium plant moved along with relative ease, the discussions between the E.U. leader and the pharmaceutical chief continued, both recounted in interviews with The New York Times.

    As they talked, the pandemic was raging across Europe, and Pfizer and BioNTech were hard at work trying to step up production. To increase the companies’ production capacity even further, the chief commercial officer at BioNTech, Sean Marett, was lining up regulatory approval for a newly acquired plant in Germany, which was already producing vaccines and stockpiling them in anticipation of getting a green light.

    By the end of March, when the plant got its authorization, it had already produced 11 million doses, which were soon directed to the European Union.

    The calls resulted in a string of deals between the European Union and the companies. On Feb. 17, the bloc announced an order for another 200 million shots. On April 19, it activated an option to get yet another 100 million.

    Accounts of how the deals came about, related by Ms. von der Leyen, Mr. Bourla, Mr. Marett and another nine officials and experts involved, reveal a striking alignment of political survival and corporate hustle.

    In her interview, Ms. von der Leyen played down the political pressures she had faced, and said she had been confident things would improve.

    “I knew that the upscaling of the deliveries would have a slow start by nature in the beginning, and therefore, I also knew the first quarter was going be tough,” she said. But, she added, “I did not expect it to be as tough, because we did not include the possibility that AstraZeneca would reduce deliveries by 75 percent. That was a heavy setback.”

    Mr. Bourla said he built a bond with Ms. von der Leyen.

    “Multiple leaders of the world, they would reach out to me, from presidents or prime ministers and kings, and general secretaries of organizations,” Mr. Bourla said.

    Mr. Bourla said he and Ms. von der Leyen had “developed a deep trust, because we got into deep discussions.” He said: “She knew details about the variants, she knew details about everything. So that made the discussion, way more engaged.”

    Despite the deals with Pfizer and BioNTech, Europe is still playing catch-up when it comes to vaccinating its citizens. As of this week, 22 percent of European Union nationals have received at least one dose of a Covid-19 vaccine, in contrast to half of Britons, 42 percent of Americans and more than 62 percent of Israelis, according to Our World in Data.
    But the European Union has now made up for the vaccine it did not get from AstraZeneca — the bloc is suing over the missed doses — and has moved forward its target date for getting 70 percent of its adults fully immunized. It is now July, instead of September.

    The bloc is already one of the world’s biggest producers and exporters of Covid-19 vaccines, with just over 159 million doses shipped to 87 countries since December. That is almost exactly as many as it has kept at home to immunize its own people.

    The agreement with Pfizer and BioNTech will stipulate that the shots be produced in Europe, bringing home not just the finished product, but also most of the 280 components that go into making it, Ms. von der Leyen and Mr. Bourla of Pfizer said.

    The contract will also allow for a range of different vaccine products.

    An internal European Commission assessment of the bloc’s needs over the next two years, which is still being reviewed and was seen by The Times, lays out ballpark figures for how many doses might be necessary under different scenarios, although not all these needs would necessarily be covered by the Pfizer contract. According to the draft assessment, the bloc might require up to 510 million booster doses in 2022 and 2023.

    Mr. Bourla said he expected a booster would be needed six to twelve months after people get their second shot, although some public health experts note that it is not clear yet whether that will be necessary. And the assessment includes a worst-case scenario for a new vaccine to target an “escape mutant,” a variant of the coronavirus that is too resistant to existing shots.
    The draft says the European Union would require 640 million doses of this type of vaccine for two doses per adult. And it puts the number of pediatric vaccines at 130 million for 2022 and 65 million for 2023.

    The deal is not without risks, or critics. Countries and experts worry that the European Union may be becoming too dependent on Pfizer, and failing to hedge its bets in the event of problems with the vaccine or its production.

    “I would caution against going for Pfizer/BioNTech only,” said Prof. Peter Piot, a microbiologist who advises Ms. von der Leyen. “That is too high risk for me, scientifically,” he said, though he noted that mRNA technology vaccines like Pfizer’s have so far been working well.

    Of the new E.U. deal with Pfizer, Professor Piot said, “My interpretation is, what works is who can deliver.”

    Ms. von der Leyen said the European Union could still procure doses from other companies.

    She said the bloc was following the development of protein-based vaccines made by Novavax and Sanofi, as well as mRNA vaccines from Moderna, which are already being used in Europe, and CureVac, which is under review by the E.U. regulator. The Johnson & Johnson vaccine, which was rolled out in Europe this month, is also attractive because of its single-dose regimen and easy storage, she said.

    The Pfizer shot is also expensive. While the financial details of the new agreement have not been disclosed, the previous contract priced the shot at approximately 15.5 euros, or about 19 dollars, making it the second-most expensive vaccine in the region after Moderna.

    European Union members will each decide whether they want to use their full allocations of doses, or leave some for others to absorb, or to be resold or donated. They will also be free to make bilateral agreements with other pharmaceutical companies for vaccines in the future.

    The new contract does little to address mounting global calls for the release of patents or for technology transfers to ensure that more of the world gets vaccinated soon. With India in the throes of a catastrophic wave of the virus, and the majority of the world’s population still far from getting access to a first dose of any vaccine, Europe’s talk of doses for children and boosters seems out of step with global needs, health experts say.

    And while Ms. von der Leyen says the deal will enable the European Union to help poorer regions, it reinforces the fact that the rich are still coming first in the global scramble for vaccines.
    Siddartha Sankar Datta, a senior official with the World Health Organization in Europe, said he worried about how the deal would affect global supply.

    “I think the bottom line should be that the access to this vaccine should not be a prerogative of the purchasing power of the country,” he said. He said, “As countries make the effort to ensure their population base gets benefits, we have to still keep pushing ourselves to ensure more equitable access.”

    Still, for Ms. von der Leyen, and for the European Union, the deal with Pfizer and BioNTech offers a chance to remedy past mistakes.

    “Europe has decided to make sure that, under any circumstances, they will be prepared if there’s more need, and as a consequence of that political decision, they are now prepared to take much bigger risks,” said Moncef Slaoui, who led the U.S. vaccine effort Operation Warp Speed, and is in frequent contact with Ms. von der Leyen on E.U. strategy.

    “Politics and science are intertwined here,” he said.


    • at 1 min 36 :

      .. what science tells us already is that full vaccination and boosters provide the strongest protection against covid that is available now

      […]on one hand you have the virus and the variants and and on the other hand we have vaccination and boosters


    • BBC – ‘Pfizer boss: Annual Covid jabs for years to come

      People will be likely to need to have annual Covid vaccinations for many years to come, the head of Pfizer has told the BBC

      Dr Albert Bourla said he thought this would be needed to maintain a “very high level of protection”.

      The UK has now secured an extra 114 million doses of Pfizer and Moderna vaccines to be delivered over the next two years.

      A year ago the UK was the first country to approve the Pfizer-BioNTech vaccine.

      Pfizers’s chief executive was speaking to the BBC before the emergence of the Omicron variant, first identified in South Africa and also before the announcement that the UK government had signed contracts to buy the 54 million additional Pfizer-BioNTech and 60 million Moderna doses for 2022 and 2023.

      These deals include access to modified vaccines if needed to combat Omicron and future variants of concern, the Department of Health has said.

      Dr Bourla said Pfizer had already made updated vaccines in response to the Beta, also first identified in South Africa, and Delta, first identified in India, variants but that they had not been needed.

      The company is now working on an updated jab in response to the Omicron variant that could be ready in 100 days.

      He said vaccines had helped save millions of lives during the pandemic,and without them the “fundamental structure of our society would be threatened”

      By the end of the year Pfizer expects to have supplied three billion doses of its messenger ribonucleic-acid (mRNA) vaccine with four billion planned for next year.

      There had been a global race to protect people protected, Dr Bourla said, but in 2022, countries would have “as many doses as they need”.

      Share price
      Several global health charities see the money Pfizer, BioNTech and Moderna are making out of the pandemic as immoral.

      Pfizer will generate at least $35bn of Covid vaccine sales this year and has seen its share price soar.

      But while most people in the world have now had at least one Covid jab, in parts of Africa it is less than one person in 20.

      Dr Bourla was unapologetic about making a profit, saying “the bottom line is millions of lives were saved.”

      He continued; “We have saved the global economy trillions of dollars.

      “It is a strong incentive for innovation for the next pandemic.

      “But people will see that if they step up to the game, to bring something that saves lives and saves money, there is also a financial reward.”

      He denied profiteering – saying the jab was the “cost of a takeaway meal” for richer countries but sold at no profit to low-income ones – but accepted rich countries such as the UK had placed orders early and availability had initially been limited.

      Having to be stored at -70C, the Pfizer vaccine has been tricky to deploy in countries with limited health services.

      But within a month or so, Pfizer says it will roll out a new formulation of the vaccine that can be stored for three months in a fridge, which Dr Bourla said, would make a “huge difference” for sub-Saharan African countries.

      Pfizer has also developed an antiviral pill, Paxlovid, which in trials cut hospital admissions and deaths by nearly 90%.

      It should be approved in the US shortly and the UK government has agreed to buy enough for 250,000 patients.

      ‘Severe symptoms’

      Pfizer is also conducting Covid-vaccine trials in the under-fives.

      And in October, the United States Food and Drug Administration approved the Pfizer jab for five to 11-year-olds.

      Immunising that age group in the UK and Europe would be a very good idea, Dr Bourla said.

      “Covid in schools is thriving,” he said.

      “This is disturbing, significantly, the educational system, and there are kids that will have severe symptoms.

      “So there is no doubt in my mind that the benefits, completely, are in favour of doing it.”

      The mRNA vaccines, from Pfizer and Moderna have now taken over almost completely from the UK developed Oxford-AstraZeneca jab.

      ‘Right thing’
      And Dr Bourla had a strong message for those who did not want to have vaccines.

      “For those that are just afraid, the only emotion of human beings stronger than fear is love,” he said.

      “So I am using always this argument that the decision to get another vaccine is not going to influence only your health, it is going to affect the health of others and particularly the health of the people you love the most, because they are the ones that you will interact with.

      “So take the courage to overcome your fears and do the right thing.”

      He has recently been the target of some bizarre fake news stories, alleging the US Federal Bureau of Investigation had arrested him for fraud and his wife had died as a result of side-effects from the Pfizer vaccine – both untrue.

      “In the first news, that I was arrested by the FBI, of course I laughed,” he said.

      “On the second news, that my wife died, with a picture of her, I was really [angry].

      “I worried about my kids, so I tried to call them and I could not get my son on the phone.

      “What we had to go through, it is nothing compared to the lives that will be lost because of the rubbish that those people published, because people will really think that my wife died because of the vaccine… and she is fine – she is wonderful.”

      + video

    • Bourla’s a strange critter, and this woman seems to be the product of a 3-D printer.
      This puffery is intended to make them look human. They may be, but this construct is all cardboard cutouts.

  2. the gatewaypundit – “The COVID-19 Vaccines DO NOT Prevent Transmission of the Disease” – Judge Doughty’s Ruling Destroys Biden’s Vax Mandates

    The Gateway Pundit previously reported that Louisiana U.S. District Judge Terry Doughty blocked a federal COVID-19 vaccine mandate for health care workers on Tuesday.

    The ruling by Judge Doughty follows Missouri US District Judge Matthew Schelp’s ruling on Monday that blocked mandates in 10 states.

    Judge Doughty pointed out all of the illogical and irrational contradictions in the mandate. “If boosters are needed six months after being “fully vaccinated,” then how good are the COVID-19 vaccines, and why is it necessary to mandate them?” says Judge Doughty in his ruling.

    The complainant provided evidence based on Dr. Peter A. McCullough’s declaration, “The COVID-19 vaccines do not prevent transmission of the disease among the vaccinated or mixed vaccinated/unvaccinated populations – mandatory COVID-19 vaccines for hospitals do not increase safety for employees or hospital patients. McCullough declared that additional treatment with other drugs and supplements has resulted in an 85% reduction in hospitalizations and death of high-risk individuals presenting with COVID-19.”

    Dr. McCullough revealed the current vaccines also don’t adequately cover the Delta variants.

    The Gateway Pundit also published an article in which the New England Journal of Medicine explains how COVID vaccines may produce spike proteins that may lead to myocarditis and neurological concerns.

    “In other words, even if you are fully vaccinated, you still may become infected with the COVID-19 virus,” Judge Doughty’s ruling said.

    “Although CMS spent pages and pages attempting to explain the need for mandatory COVID-19 vaccines, when infection and hospitalizations rates are dropping, millions of people have already been infected, developing some form of natural immunity, and when people who have been fully vaccinated still become infected, mandatory vaccines as the only method of prevention make no sense,” the ruling continued.

    The Gateway Pundit previously reported that the Centers for Disease Control and Prevention (CDC) COVID response team published a study on medRxiv – a collaborative project jointly run by Cold Spring Harbor Laboratory, Yale University, and BMJ, a global healthcare knowledge provider – concluded that there is no significant difference in transmission potential of vaccinated and unvaccinated persons infected with the COVID-19 “Delta variant” in federal prison during an outbreak between July to August 2021.

    Read the court ruling here:


    • He he he. Dr. McCullough makes an excellent expert and American jurisprudence solely relies on these experts. Add in Dr. Mercola and Judy Mikovtiz and it’s checkmate Fauci and friends.

      We might actually win this.

  3. Some 13,000 places needed for asylum seekers in NL
    The Central Agency for the Reception of Asylum, Seekers (COA) expects to need at least 6,000 additional reception places for asylum seekers in 2022. The COA expects to need 42,000 reception places next year. At the end of December this year, there will be approximately 36,000 reception places, all of which are occupied.
    “In addition, 80 percent of the locations that have been realized since September 2021 are temporary, in halls, river ships, and the like. Many agreements already expire in the first and second quarter of 2022,” the COA said in a press release. This concerns about 7,000 temporary places, which the COA would prefer to replace with permanent reception places. If the temporary reception places expire, this will mean a shortage of beds for 13,000 asylum seekers.
    “In the coming months, we must realize sufficient additional places in time and work on future-proof solutions,” said chairman of the COA board Milo Schoemaker. “This is in the interest of our residents, the municipalities, and the COA employees.”
    In recent months it was often too crowded in the overnight shelter at the application center in Ter Apel. The overnight shelter has room for 275 people, but sometimes hundreds more people slept there. In some cases, that meant sleeping on chairs.
    A significant problem is the transfer of refugees to a home because of the large housing shortage in the Netherlands. There are currently 11,000 refugees staying in COA asylum centers. Some 7,000 have been waiting for a home for more than three months. They have a residency permit to stay in the Netherlands, and the intention is to have housing within 14 weeks.

  4. C’mon, man, the unvaccinated are the spreaders of :
    Alpha (B. I. I. 7)
    Beta (B. I. 351)
    Gamma (P. I)
    Delta (B. I. 617. 2)
    Omicron (B. I. I. 529)
    Fauci Flu ( B. S.)

  5. Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning
    Steven R Gundry
    Originally published8 Nov 2021Circulation. 2021;144:A10712

    This article has an expression of concern


    Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.

    • That is only the abstract and even that has numerous errors in it – there is no data given so one would not know if the findings are statistically significant.

      THE WORST PART is that it is written by Steven R. Gundry – who is a really weird dude. I thought he was a poof but he is married to a lady named Penny and they live in Palm Springs (which would raise red flags for some, vacation spot for West Hollywood, if you know what I mean).

      This “physician”, who does have some really nice ties, got me to stop eating tomatoes for at least six months a couple of years ago with his click bait presentations which are all over the net.

      At the time, the information was really sketchy but I now see he has a list of good foods and bad foods on his website. He related the bad foods to blood inflammation that could cause heart problems (sound familiar?)

      Anyways YMMV but don’t get too excited by this guy’s findings until they are peer reviewed. The American Heart Association called him out on this abstract BTW….

  6. Eighty House Republicans voted with Democrats on Tuesday to pass the Immunization Infrastructure Modernization Act, which if passed by the Senate and signed into law would fund a federal vaccination database. Dan Crenshaw, Kevin McCarthy, and Burgess Owens all voted yes on the measure.

    According to the bill, also called H. R. 550, the government would provide $400 million in taxpayer dollars to fund “immunization system data modernization and expansion,” a system otherwise defined as “a confidential, population-based, computerized database that records immunization doses administered by any health care provider to persons within the geographic area covered by that database.”

    The text specifically outlines an expansion of Centers for Disease Control and Prevention (CDC) and Public Health Department capabilities and the ability for state and local health departments, as well as public and private health care providers, to share health data with the federal government.

    • ABC News – Moderna scientist racing to tweak vaccine to block omicron variant

      Although it has not been confirmed that a new vaccine will be needed to fight the latest omicron variant of COVID-19, scientists are researching ways to tweak their shots just in case.

    • global news – More Canadians starting to receive their 3rd vaccine dose

      Provinces are rolling out more COVID-19 booster shots to vaccinated Canadians as the country remains focused on battling the still dominant Delta variant.

      Several provinces are adhering to the National Advisory Committee’s October recommendations to offer boosters to anyone aged 70 or older, along with vulnerable groups.

      But some provinces are already getting ahead, with Ontarians aged 50 and over being able to get theirs starting Dec. 13.

    • global news – South Africa’s infections nearly double in 1 day amid Omicron variant

      South Africa is struggling with a sharp rise in COVID-19 cases as the Omicron variant continues to spread.

      The Omicron variant is now dominant there, with 70 per cent of all the virus’ genomes the country sequenced last month having been of the new variant. Infections have also recently doubled there in nearly 24 hours.

      About 36 per cent of adults in South Africa are fully vaccinated, according to official statistics.

    • reuters – Vaccine makers right to plan for adjustments to COVID-19 shot, says WHO

      The WHO’s spokesman Christian Lindmeier said that the agency was still studying the transmissibility and severity of the Omicron coronavirus variant and it was right for vaccine manufactures to plan ‘for the likelihood for having to adjust the existing vaccine.’

      • Reuters’s CEO, James C Smith sits on the Board of Directors for Pfizer. No conflict there however, he is one of the chosen few.

    • CBC – New vaccine guidance coming as omicron variant spreads

      Dr. Sumon Chakrabarti, an infectious diseases physician with Trillium Health Partners in Ontario’s Peel Region, says the omicron variant of the coronavirus is informing decisions on booster shots and travel restrictions.

      • Canadians should check out “How to renew your passport.” We no longer live in a democracy and Justine Trudeau is now the dictator.

      • My heathcare advocate (a nurse practioner) is a fanatic. Got covid in March 2020, gave it to her whole family. Has had several patients die. She got double-Pfizer-ed plus booster.

        But now she understands why I won’t be getting a booster. (I said “For a while, anyway. Till things get sorted out…)

        Teams came to our buildings in early March, then returned on schedule for the second shot.
        That was well over six months ago. So why haven’t they pushed boosters?

        To many people here, Moderna corporate management now looks like a gang of marketers, stock manipulators, and grifters. They’ve lost key research personnel.

        We may be looking at things in the rearview mirror…

      • Hate speech is not allowed under this pompous, Jackass, but I hate the sight of globalist bastard, is he having a hard time not laughing at what he is proposing?

    • Ireland: Face mask rules for children spark protest in Dublin

      Crowds of demonstrators gathered in Merrion Square, Dublin, on Friday, in protest of a new set of COVID-19 rules targeting children.

      Participants could be seen holding signs against the new regulations, with several children also in attendance.

      On Wednesday, the government declared that children aged 9 and above should wear masks in schools, shops, and public transport, and recommended that parents limit indoor socialisation between youngsters.

      In addition, both vaccinated and non-vaccinated travellers to the country will be required to take a PCR test or lab-administered antigen test upon arrival.

    • Government of Canada signs agreements for COVID-19 oral antiviral treatments

      […]the Government of Canada has signed agreements with Merck and Pfizer for access to their COVID-19 oral antiviral treatments.

      The agreement with Merck provides Canada with 500,000 courses of its COVID-19 oral antiviral treatment, molnupiravir, with options for up to 500,000 more, pending Health Canada authorization.

      The agreement with Pfizer provides Canada with an initial quantity of 1 million courses of its COVID-19 oral antiviral treatment, pending Health Canada authorization. Pfizer submitted a rolling submission for authorization to Health Canada earlier this week.

      Health Canada is prioritizing the review of all COVID-19 vaccines and drugs. Deliveries of these treatments are expected to start following Health Canada authorization of the treatments.

      Vaccination remains the best way to protect public health from COVID-19. However, effective, easy?to?use and accessible treatments, such as the ones produced by Merck and Pfizer, will be critical to reducing the severity of COVID-19 illness and will help save lives.



      Canada secures orders of Merck, Pfizer COVID-19 antiviral pills

      The federal government has signed purchase agreements with two pharmaceutical companies for their oral COVID-19 treatments.

      Filomena Tassi, Canada’s minister of public services and procurement, told reporters on Friday the government has signed agreements with Pfizer and Merck to buy up to 1.5 million courses of their antiviral treatment, PF-07321332 and Molnupiravir.

      “We also know that access to effective, easy-to-use treatments is critical to reducing the severity of COVID infections and will help save lives,” she said.

      “As soon as these drugs are authorized for use, the government will work on getting them to provinces and territories as quickly as possible so that health-care providers can help Canadians who need them most.”

      As part of its initial order, the government has reached an agreement with Pfizer for one million courses of its treatment, pending Health Canada approval.

      The government’s deal with Merck is for up to 500,000 courses of its treatment, with an option to add 500,000 more pending approval, Tassi added.

      […]Labos also pointed out that vaccines are cheaper than the pills, which he said are “rather expensive,” and real-world data is needed to see if their benefit outweighs the cost.

      Another concern is the logistics of treating patients with the pills since they have to be administered within five days of infection, according to Labos.

      “We’re going to have to make sure that there is a pathway in place for these medications to actually get to the patients for them to be effective,” he said.

      “If you start too late in the course, it’s doubtful they’re going to have much of an impact.”

    • Delta vs. Omicron: CDC Director Discusses Coronavirus Variants

      Rochelle Walensky says the agency is carefully watching new omicron cases in the U.S., while a majority of new Covid cases are from the delta variant.

      Walensky warns travelers to get their booster shots and take health precautions. »

    • ctv news –Canada will have enough doses for everyone to get COVID-19 boosters: Tassi

      Minister Filomena Tassi discusses new NACI recommendations that booster doses of COVID-19 vaccines be given to all Canadians 50+.

    • CBC – Canada’s deputy public health officer explains the country’s booster strategy

      Canada’s Deputy Chief Public Health Officer Dr. Howard Njoo explains the National Advisory Committee on Immunization’s updated recommendations for COVID-19 vaccine booster shots.

    • HK scientists successfully isolate Omicron from COVID-19 samples

      Scientists in Hong Kong Special Administrative Region (SAR) say they have become the first in Asia to successfully isolate the Omicron variant from COVID-19 samples.

      They’re now working with drugmakers on the Chinese mainland to develop a vaccine to combat the new variant.

    • city news – Montreal clinical trial to vaccinate babies with COVID-19 shot

      “Families are excited to help out and see if we can get another vaccine approved in kids,” says Dr. Soren Gantt, leading a Montreal study on safety and efficacy of Moderna’s COVID-19 vaccine for children as of six months.

      + comments on the YT page

  7. DAILY MAIL – Delta passenger on a flight from Syracuse to Atlanta was ‘breastfeeding her hairless CAT and refused to stop’

    Incident allegedly happened aboard Delta Flight 1360 from Syracuse, New York, to Atlanta

    Message sent by crew member through Aircraft Communications Addressing and Reporting System claims passenger was breastfeeding her cat

    Delta staffer requested that flight be met by Red Coats, who are elite airport customer service experts

    Flight attendant claimed in a TikTok video the pet owner lifted her shirt and was trying to get her swaddled and screaming hairless cat ‘to latch’


  8. There’s an update on the Kurds storming the offices of the OPCW, 50 protesters arrested. Same link as posted earlier:

    The organisation behind it is called DEM NED:

    There was a similar protest in Lausanne, Switzerland last week:
    For weeks, Kurdish organizations in Europe and beyond have been protesting the Turkish state’s use of banned chemical weapons in Kurdistan. In the course of the occupation operation launched in April in the Medya defense areas in southern Kurdistan (northern Iraq), the Turkish army has used chemical weapons hundreds of times against the guerrillas. Various poisonous gases have been used, resulting in the immediate death of guerrilla fighters in dozens of cases. Survivors report various substances affecting the nervous system or causing asphyxiation. According to the People’s Defense Forces (HPG) statement published on October 24, 38 fighters have died from poison gas since the beginning of the year, and 323 chemical weapons attacks have taken place up to this point.

    Apparently Turkey has been using chemical weapons against Kurds in Syria and Iraq since April:

    It is nothing new. Btw check the last photo, crescent moon over swastika:

    Turkey has bought chemical weapons from Nazi Germany for Dersim massacre
    New documents reveal that the founder of Turkey, Ataturk bought chemical weapons from Nazi Germany (1937) and used it for the Alevi massacres in Dersim.
    The Turkish state killed thousands of civilians in Dersim, Northern Kurdistan, in 1937-1938.
    The documents show that Atatürk ordered that toxic gas be transported to Elaziz (Elazig) and be used against civilians in Dersim, Kurdistan.
    Former Turkish Minister of Foreign Affairs Ihsan Sabri Caglayangil admitted that the Turkish army used chemical weapons against women and children trapped in caves and exterminated the entire population of Dersim.
    Nazi Germany has delivered Turkey the Heinkel planes. Chemical attacks in Dersim were carried out by these planes. Sabiha Gokçen, Atatürk’s adopted daughter, was one of the pilots flying on Dersim when Turkish aviation dumped toxic gas on the Kurdish population.

    Turkey’s history of chemical weapons use
    The first document relates to a Turkish Army Forces (TSK) General Staff Ground Forces Command instruction regarding the use of chemical warfare that was dated 25 February 1986. The document was signed by general Necdet Öztorun. That document was also put on the agenda for discussion by German public opinion. However, it remained inconclusive. Meanwhile, Turkey has not hidden the fact that it has kept chemical weapons in its military inventory.
    Bradford University in the United Kingdom reported in 2010 that Turkey’s Machine and Chemistry Industry Organisation (MKEK) had produced CS bombs and sold it in international markets.
    It has also been reported that footage, which pointed to Turkey’s use of chemical weapons against PKK guerrillas, was taped in 1999. The Turkish army also reportedly murdered 20 Peoples Liberation Army of Kurdistan (ARGK) guerrillas in a cave located in Ball?kaya village of ??rnak on 11 March 1999. “Our soldiers are facing danger of being poisoned now. But still they are entering heroically and bravely … Though we gave a break of one day, the gas still preserves its effect”, soldiers are heard saying in footage that was taken by the Turkish army and later broadcast on Roj TV. [..]
    That massacre carried out in Ball?kaya was placed on the German Federal Parliamentary agenda by PDS in 1999 and by the Left Party in 2011. An examination conducted by a Münich University Forensic Medicine team found chemical residues on parts of bombs that were examined.

  9. – RUMBLE is going places. –

    Neutral video platform Rumble to go public under ticker CFVI

    Rumble, a censorship-free video platforms alternative to YouTube, has entered an acquisition deal with Cantor Fitzgerald-sponsored CF Acquisition Corp. VI (CFVI). After the completion of the business combination deal in the second quarter of 2022, the company will be known as Rumble Inc. and will be publicly listed.

  10. IF you walk across into Canada at Roxham Road, I would remind you of the lyrics of the Eagles’ song Hotel California:

    “Last thing I remember, I was
    Running for the door
    I had to find the passage back
    To the place I was before.
    “Relax”, said the night man,
    We are PROGRAMMED to receive,
    You can check-out any time you like,
    But you can never leave”.

    If you are a Canadian, now not allowed to leave Canada, screwed by the useful idiots, that some fearful, feckless, Canadians elected, you might take a look at Twisted Sister’s lyrics “We’re NOT Gonna take it anymore.”

    And hope that not everyone has not gone totally mad.

  11. PAKISTAN: Terrible story although a repeat of many such stories occurring in savagery-laden Pakistan.

    ‘Son Of A Kaafir Threw Verses Of Quran In Dustbin’. Fanatics In Pakistan Kill And Burn Sri Lankan National Over ‘Blasphemy’

    In a bone-chilling case of barbarity, a fanatic crowd in Pakistan killed and burnt a factory manager accusing him of disrespecting Quran on Friday (3 December).

    The victim has been identified as Priyantha Kumara, a Sri Lankan national, as per various reports.

    (Note: I was reading the victim was the director of a facility and he removed some old posters from a wall. On one or two of the posters, there were one or two small words – probably Mohamed – and the whole place blew up in fury.)

Leave a Reply

Your email address will not be published.